Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco G Gogliotti

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Trends in Pharmacological Sciences|March 26, 2019
A Coordinated Attack: Rett Syndrome Therapeutic DevelopmentRocco G Gogliotti, Colleen M Niswender
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?Rocco G Gogliotti, P Jeffrey Conn
Neuropharmacology|March 6, 2022
Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndromeSheryl Anne D Vermudez, Aditi Buch, Kelly Weiss, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Potentiation of the M <sub>1</sub> muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in <i>Mecp2</i><sup>+/-</sup> miceMackenzie Smith, Grace E Dodis, Amanda M Vanderplow, et al.
Neuroscience|February 1, 2026
Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapySheryl Anne D Vermudez, Geanne A Freitas, Mackenzie Smith, et al.
Neurobiology of Disease|February 28, 2025
Potentiation of the M<sub>1</sub> muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in Mecp2<sup>+/-</sup> miceMackenzie Smith, Grace E Dodis, Amanda M Vanderplow, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 15, 2017
Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5Branden J Stansley, Nicole M Fisher, Rocco G Gogliotti, et al.
RNA (New York, N.Y.)|October 8, 2024
Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expressionAmanda M Vanderplow, Grace E Dodis, Yewon Rhee, et al.
Molecular and Cellular Neurosciences|April 17, 2026
Increasing MeCP2 protein in Pitt-Hopkins syndrome model (Tcf4<sup>+/-</sup>) mice does not affect abnormal myelination but induces the generation of astrocytesSheryl Anne D Vermudez, Geanne A Freitas, Aditi Buch, et al.
ACS Chemical Neuroscience|June 7, 2022
Optimized Administration of the M<sub>4</sub> PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in <i>Mecp2</i><sup></sup> MiceJakub Cikowski, Calista Holt, Bright Arthur, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Trends in Pharmacological Sciences|March 26, 2019
A Coordinated Attack: Rett Syndrome Therapeutic DevelopmentRocco G Gogliotti, Colleen M Niswender
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 15, 2015
Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?Rocco G Gogliotti, P Jeffrey Conn
Neuropharmacology|March 6, 2022
Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndromeSheryl Anne D Vermudez, Aditi Buch, Kelly Weiss, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Potentiation of the M <sub>1</sub> muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in <i>Mecp2</i><sup>+/-</sup> miceMackenzie Smith, Grace E Dodis, Amanda M Vanderplow, et al.
Neuroscience|February 1, 2026
Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapySheryl Anne D Vermudez, Geanne A Freitas, Mackenzie Smith, et al.
Neurobiology of Disease|February 28, 2025
Potentiation of the M<sub>1</sub> muscarinic acetylcholine receptor normalizes neuronal activation patterns and improves apnea severity in Mecp2<sup>+/-</sup> miceMackenzie Smith, Grace E Dodis, Amanda M Vanderplow, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 15, 2017
Contextual Fear Extinction Induces Hippocampal Metaplasticity Mediated by Metabotropic Glutamate Receptor 5Branden J Stansley, Nicole M Fisher, Rocco G Gogliotti, et al.
RNA (New York, N.Y.)|October 8, 2024
Site-blocking antisense oligonucleotides as a mechanism to fine-tune MeCP2 expressionAmanda M Vanderplow, Grace E Dodis, Yewon Rhee, et al.
Molecular and Cellular Neurosciences|April 17, 2026
Increasing MeCP2 protein in Pitt-Hopkins syndrome model (Tcf4<sup>+/-</sup>) mice does not affect abnormal myelination but induces the generation of astrocytesSheryl Anne D Vermudez, Geanne A Freitas, Aditi Buch, et al.
ACS Chemical Neuroscience|June 7, 2022
Optimized Administration of the M<sub>4</sub> PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in <i>Mecp2</i><sup></sup> MiceJakub Cikowski, Calista Holt, Bright Arthur, et al.
Pageof 3